UN Political Declaration on Non-Communicable Diseases

UN Political Declaration on Non-Communicable Diseases
Name	UN Political Declaration on Non-Communicable Diseases
Date adopted	2011-09-19
Adopted by	United Nations General Assembly
Location	United Nations Headquarters, New York City
Related documents	Global action plan for the prevention and control of NCDs 2013–2020, WHO Framework Convention on Tobacco Control, Sustainable Development Goals
Subject	Non-communicable diseases
Languages	Arabic language, Chinese language, English language, French language, Russian language, Spanish language

UN Political Declaration on Non-Communicable Diseases. The UN Political Declaration on Non-Communicable Diseases is a consensus resolution adopted at the United Nations General Assembly high-level meeting in New York City addressing the global burden of cardiovascular disease, cancer, chronic respiratory disease, and diabetes mellitus. It built on prior agendas from World Health Organization assemblies, World Health Assembly resolutions, and country-level commitments such as those from United States, United Kingdom, India, China, and Brazil. The Declaration influenced subsequent instruments like the Global action plan for the prevention and control of NCDs 2013–2020 and aligned with targets within the 2030 Agenda for Sustainable Development and the Sustainable Development Goals.

Background and Rationale

The Declaration emerged from rising mortality and morbidity data reported by the World Health Organization and analyses from organizations including the World Bank, OECD, Pan American Health Organization, European Commission, African Union Commission, and Asian Development Bank. Epidemiological trends documented by research institutions such as Harvard School of Public Health, Johns Hopkins Bloomberg School of Public Health, Imperial College London, Karolinska Institutet, and University of Oxford highlighted risk factors like tobacco use addressed by the WHO Framework Convention on Tobacco Control, unhealthy diets influenced by Nestlé, PepsiCo, and Unilever supply chains, physical inactivity documented by International Olympic Committee studies, and harmful use of alcohol involving companies such as Diageo and Anheuser-Busch InBev. Global health diplomacy forums including the High-level Meeting of the General Assembly on NCDs, the UN Secretary-General office, and coalitions like NCD Alliance and Global Health Council framed NCDs as development and human rights issues referencing instruments like the Universal Declaration of Human Rights and the International Covenant on Economic, Social and Cultural Rights.

Adoption and Content

Adopted on 19 September 2011 at the United Nations General Assembly high-level meeting, the Declaration was negotiated among member states including United States, India, South Africa, Russia, Japan, Canada, Germany, France, and Australia. It reaffirmed commitments from prior instruments such as the WHO Global Strategy on Diet, Physical Activity and Health and the Alma-Ata Declaration influences while invoking leadership from institutions like the United Nations Development Programme, United Nations Children's Fund, World Bank Group, International Monetary Fund, and World Trade Organization. The text called for multisectoral responses engaging ministry of health counterparts across national systems and emphasized interventions endorsed by WHO, Lancet commissions, and technical guidance from bodies such as the Global Fund to Fight AIDS, Tuberculosis and Malaria and Gavi, the Vaccine Alliance.

Global Implementation and Policy Impact

Following adoption, countries including Brazil, Mexico, Turkey, Thailand, South Africa, Kenya, Uganda, Rwanda, Philippines, and Indonesia developed national NCD plans informed by tools from the WHO Regional Office for Europe, WHO Regional Office for Africa, and the Pan American Health Organization. Policy measures inspired by the Declaration included taxation policy examples in Finland and Estonia mirroring Mexico's soda tax, tobacco control measures aligned with the WHO Framework Convention on Tobacco Control adopted in Australia and Norway, and salt reduction initiatives modeled on programs in United Kingdom and Japan. Development partners such as Bill & Melinda Gates Foundation, Rockefeller Foundation, Clinton Health Access Initiative, and Global Health Innovative Technology Fund supported implementation research at institutions like London School of Hygiene & Tropical Medicine, University of Toronto, McGill University, and National Institutes of Health.

Monitoring, Targets, and Accountability

The Declaration catalyzed measurable targets that were integrated into the Sustainable Development Goals particularly SDG 3 and its target 3.4, and aligned with WHO's 25 by 25 and subsequent 30 by 30 mortality reduction frameworks developed by WHO Director-General offices and endorsed by the World Health Assembly. Monitoring mechanisms involved data platforms maintained by WHO Global Health Observatory, statistical inputs from United Nations Statistics Division, burden estimates from the Global Burden of Disease Study coordinated by Institute for Health Metrics and Evaluation, and reporting to the High-level Political Forum on Sustainable Development. Accountability dialogues featured participation from World Health Assembly delegates, International Agency for Research on Cancer, Food and Agriculture Organization, United Nations Educational, Scientific and Cultural Organization, and civil society groups including the NCD Alliance and Global Coalition for NCDs.

Stakeholder Roles and Partnerships

The Declaration envisaged roles for member states, multilateral agencies, philanthropic actors, academia, and private sector entities such as Nestlé, PepsiCo, Diageo, Philip Morris International, British American Tobacco, Unilever, Johnson & Johnson, Pfizer, and Novartis. Partnerships emerged involving World Bank, Asian Development Bank, African Development Bank, European Investment Bank, and public–private collaborations like projects with Gavi, the Vaccine Alliance and the Global Fund. Civil society and professional associations including World Medical Association, International Diabetes Federation, Union for International Cancer Control, American Heart Association, European Society of Cardiology, and patient groups such as International Alliance of Patients' Organizations contributed to advocacy, surveillance, and service delivery innovations at sites including Aga Khan University and Makerere University.

Criticisms and Debates

Scholars and advocacy networks raised concerns about the Declaration's limitations, citing debates involving World Health Organization governance, conflicts of interest discussions featuring Philip Morris International and British American Tobacco, and critiques from public health academics at Harvard T.H. Chan School of Public Health, Yale School of Public Health, and University College London. Critics argued the Declaration lacked binding enforcement compared with treaties like the WHO Framework Convention on Tobacco Control and pointed to uneven implementation illustrated by outcomes in Mauritius, Solomon Islands, Kazakhstan, and Fiji. Policy analysts from Chatham House, Council on Foreign Relations, Brookings Institution, Carnegie Endowment for International Peace, and RAND Corporation debated private sector engagement models versus state-led regulation, while ethics scholars at Oxford University and Cambridge University discussed human rights implications and distributive justice referenced in the International Covenant on Civil and Political Rights.

Category:United Nations documents